Valneva shares fall as French health body advises against its COVID-19 vaccine

PARIS (Reuters) - Shares in France's Valneva reversed course on the Paris stock market and traded down by around 2.8% after the country's public health authority said it would advise the government not to use the company's COVID-19 vaccine for its vaccination strategy.

(Reporting by Tassilo Hummel; Editing by Sudip Kar-Gupta)